Companies: 10,795·Total market cap: $144.5T
Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.

MNMDNASDAQHealthcare
$20.69
+$0.09(+0.44%)
Market Cap$1.6B
P/E Ratio
52W High$21.08
52W Low$4.7

Mind Medicine (MindMed) Inc. (MNMD) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · MNMD · as of Sep 30, 2025

Ownership Breakdown

Institutions 52.6%
Insiders 2.8%
Public 44.6%

208

Institutional Holders

▲ 17 vs Q2

$468.54M

Total Inst. Value

▲ $197.52M vs Q2

75.55M

Shares Outstanding

freeFloat 97.20%

39.74M

13F Shares Held

▼ 2.06M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

MNMD largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

BLACKROCK, INC.

medicinal chemicals & botanical products

5.94M6.91%

6.91%

$69.98BNov 12, 2025 133.4K

COMMODORE CAPITAL LP

medicinal chemicals & botanical products

3.23M3.75%

3.75%

$38.02BNov 14, 2025 1.77M

DRIEHAUS CAPITAL MANAGEMENT LLC

medicinal chemicals & botanical products

3.11M3.62%

3.62%

$36.67BNov 14, 2025 17.3K

BLACKSTONE INC.

medicinal chemicals & botanical products

2.78M3.23%

3.23%

$32.74BNov 14, 2025 810.9K

MARSHALL WACE, LLP

medicinal chemicals & botanical products

2.38M2.77%

2.77%

$28.08BNov 13, 2025 1.04M

OCTAGON CAPITAL ADVISORS LP

medicinal chemicals & botanical products

2.13M2.48%

2.48%

$25.11BNov 14, 2025— held

VANGUARD GROUP INC

medicinal chemicals & botanical products

2.01M2.34%

2.34%

$23.73BNov 7, 2025 198.9K

STATE STREET CORP

medicinal chemicals & botanical products

1.92M2.24%

2.24%

$22.69BNov 14, 2025 119.0K

GEODE CAPITAL MANAGEMENT, LLC

medicinal chemicals & botanical products

1.82M2.12%

2.12%

$21.52BNov 12, 2025 91.2K

DEEP TRACK CAPITAL, LP

medicinal chemicals & botanical products

1.50M1.75%

1.75%

$17.68BNov 14, 2025 1.00M

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

24

Increased

+3.09M shares

8

New Positions

first time holders

14

Decreased

−5.36M shares

0

Sold Out

fully exited

Net shares change (top 50)

2.27M

+3.09M / −5.36M

Net new holders

+18

8 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

MNMD insider trading · insider activity

Source: SEC Form 4

0

Buy transactions

3

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Makes Brigid

director

Jun 1, 2022Award361,680643.8KForm 4 ↗

Makes Brigid

director

Jun 1, 2022Award100,308$0.60$60.2K194.4KForm 4 ↗

Makes Brigid

director

Jun 1, 2022Award64,656158.7KForm 4 ↗

Greenway Schond L.

Chief Financial Officer

May 23, 2022Award1,650,000$0.71$1.17M1.65MForm 4 ↗

Greenway Schond L.

Chief Financial Officer

May 23, 2022Award1,270,0001.27MForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Mind Medicine (MindMed) Inc. (MNMD) is primarily owned by institutional investors, who hold approximately 52.6% of total shares outstanding. Company insiders own approximately 2.80%, while retail and public investors account for the remaining 44.60%.

The largest institutional shareholder of Mind Medicine (MindMed) Inc. is BLACKROCK, INC., holding approximately 5.94 million shares — equal to 6.91% of outstanding shares — as of September 30, 2025.

A total of 208 institutional investors currently hold MNMD stock, with a combined institutional value of approximately $468,541,781 as of the most recent 13F filing period.

Frequently asked questions

MNMD ownership

Mind Medicine (MindMed) Inc. (MNMD) is primarily owned by institutional investors, who hold approximately 52.6% of shares. The largest shareholder is BLACKROCK, INC. with a 6.91% stake. Company insiders hold 2.80%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns MNMD stockMNMD ownership structureSEC Form 13F institutional holdingsMNMD float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025